chrisvoncsefalvay/vaers-outcomes huggingface dataset:
During monitoring period post Pfizer vaccine #1 COVID-19 vaccine, pt experienced Nausea, Lightheadedness, Lip tingling, Hypertension, Wheezing, Dizziness, Tachypnea, Heat Sensation, Dry mouth. Water provided, ice applied, then medications administered as patients symptoms were not relived.  Given PO benadryl & epi-pen. Patient reported feeling better. After extended time in Observation post vaccine, patient left the clinic in stable condition with mom and siblings.
04/05/2021 Received the Pfizer vaccine does one at 10:10 am  Reaction 1)  at 11:00am I started experiencing a very bad taste in my mouth. it was very metallic . It was not relieved by oral intake or mouthwash or teeth brushing. It lasted about 7 hours  Reaction 2) 04/05/2021  7:30pm : Overall itching torso, extremities, and chest with some tingling in my scalp. Due to my history of allergies I took an antihistamine ( Claritin) which relieved the itching. 04/06/2021 This also occurred on day two in the evening and was relieved by antihistamine . I did NOT experience shortness of breath   Reaction 3 ) 04/06/2021  at about 8:30 am I experienced intense back pain as if I had been slammed in my lower back -this lasted about 18 hours.  48 hours after the vaccine  I experienced arm discomfort, generalized fatigue and headache  but those symptoms have dissipated.  Today is 04/07/2021 and all symptoms are resolved. I am scheduled for dose 2 on 04/26/2021.
Patient had auditory hallucinations same evening as the shot, then began to have generalized weakness, worsening SIADH symptoms and visual hallucinations leading to subsequent hospitalization for 5 days and the SNF for 10 days. Never had hallucinations prior to event
Red, hot, swelling (right arm Pneumonia shot), fever 102F and 99.8F, Treatment Tylenol 500 mg, clindamycin 150 mg.
Pt to ED 6/15 for cough and sob, positive at home COVID test. COVID+ upon admission 6/15, maintained on Decadron. 6/16 pt reporting SOB and dizziness. Sepsis BPA fired score of 5. RRT not activated. VSS on 2L NC. ID on consult. Started on remdesivir. 6/18 pt remains A&Ox4 and showing no s/s of distress. Oxygen remains at 2L via NC and patient using home CPAP machine. Productive cough noted overnight. 6/19 pt remains A&Ox4 and showing no s/s of distress. 6/19 pt discharged.
Fever for over 48 hours of 102F (tried children's --Tylenol as prescribed on prior to vaccine and after the vaccine did not work). Pain anytime her leg moved. Wouldn't sleep for more than 2 hours (7 days). Wouldn't eat solids and often refused bottle (force fed fluids) for one week (7days). Swollen 2x the size at the injection site (lasted 4 days on day 5 swelling started to go down but wasn't complete till day 7). Stopped babbling (said mom only) after vaccine (day of, baby talk) until 18 months (only says 1 word often knows how to say 4 others but only said them twice each). Possible disability, will be evaluated 1/3/13.
Headache, Sedation, Myalgia, Angina, right axillary lymph node swelling and tenderness. Cardiac event ruled out in ED Narrative:
Dizziness, Myalgia, Fever, Chills, fatigue Narrative:
Patient tested positive for COVID-19 on 5/16/21. He is completely asymptomatic, and was only tested for pre op procedure. He reports that he received his first dose of Pfizer on Feb 14th, and second dose on March 7th
FEET AND ANKLE SWELLING; DIZZY; This spontaneous report received from a patient concerned a 70 year old female. The patient's height, and weight were not reported. The patient's past medical history included chemotherapy treatment. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A21A, and expiry: 23-JUN-2021) dose was not reported, administered on 08-APR-2021 10:30 for prophylactic vaccination. Concomitant medications included potassium for swelling. On 08-APR-2021, the subject experienced dizzy. On 11-APR-2021, the subject experienced feet and ankle swelling. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from dizzy on 09-APR-2021, and had not recovered from feet and ankle swelling. This report was non-serious.
Myocarditis; Pericarditis; This is a spontaneous report from a non-contactable consumer (patient) from a Pfizer-sponsored program with Regulatory Authority Support.  A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE 1, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced myocarditis, pericarditis with outcome of unknown.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
does not need to wear glasses anymore/can see fine without glasses; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (does not need to wear glasses anymore/can see fine without glasses) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (does not need to wear glasses anymore/can see fine without glasses). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (does not need to wear glasses anymore/can see fine without glasses) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       It was reported that  Patient is in his 70s.   No concomitant drug details were reported. No treatment details were reported.    This case was linked to MOD-2021-418455, MOD-2021-418640 (Link).
?Covid Arm? 2?x 2? red blotch on right arm at injection site The area is also raised and hard, but not painful.
Patient reports persistent pain in deltoid region without loss of range of motion where vaccine administered, headaches, and chest congestion. Adverse reactions started 5 days after administration of dose #2 per patient.
BREAKTHROUGH COVID INFECTION. TESTED POSITIVE ON 07/15/2021. PATIENT FULLY VACCINATED 02/17/2021.
per the EUA we have to report when the patient is admitted to hospital after vaccination. The patient was COVID-19 positive on 7/31/21
3 days after vaccine I woke up with nausea, upset stomach. Symptoms resolved within 6 hours.  1 week after vaccine, woke up at 3:00am with nausea and heat wave/chills, resolved within an hour
mom called office w/rash seen in office 17DEC96 w/dx of varicella & zovirax was prescribed;
fever, fatigue, h/a, dizziness, nausea;recv vax 10APR98;seen by MD 20APR98;
Where the vaccine was administered, the site became a raised red itchy bump. (2-20-07) on February 24th 2007 in the morning, awoke to find red itchy bumps on stomach, right arm, lower back, face and legs.
rash all over my neck; the rash is still on my neck; not feeling mouth; brain fog; Nauseous; tired; feeling weak; This is a spontaneous report from a contactable consumer (patient). A 62-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EN6205 and expiration date: Jun2021), via an unspecified route of administration, administered in Arm on 19Mar2021 (at the age of 62-year-old), as dose 2, single, for COVID-19 immunisation. Medical history included Hashimoto's disease. Concomitant medication included levothyroxine (137, 5 days a week and patient don't take it on weekend). Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EN6201 and expiration date: Jun2021), via an unspecified route of administration, administered in Arm on 26Feb2021 (at the age of 62-year-old), as dose 1, single, for COVID-19 immunisation. The patient got rash all over neck and mouth was not feeling normal, had brain fog, was nauseous, felt tired and felt weak. The rash was still on neck. The patient was tested for COVID a long time ago, but lab result was unknown. Patient did not receive any treatment, as the patient didn't want to damage the effectiveness of vaccine. The outcome of rash in neck was not recovered while for other events as unknown.  No follow-up attempts are possible. No further information is expected.
Pt given pneumococcal vaccine in clinic on 12/19/08. He had ill sensation after receiving pneumococcal vaccine with diaphoresis and abdominal discomfort. Almost immediate begun after administration of pneumococcal vaccine. No skin lesions noted and no breathing difficulty. Wonder if this is more of a vaso-vagal response in an anxious recipient of vaccine than true reaction to vaccination components (especially given the immediate onset). He was transported to the ED for further evaluation. No EKG changes were noted. Pt was found to be stable with no signs of anaphylaxis. He was given fluids and a meal and left with no complications.
Polio vaccine was given two soon. Given on 8/23/2022, not due until 8/5/2025
Information has been received from a company representative and health care facility concerning a 35 month old male patient who on 03/03/00 was vaccinated with a dose of Varivax. Subsequently, on 01/19/02, the patient presented to the physician's office with chickenpox. It is reported that patient broke out in a rash all over his body and this was not a mild, but a serious case of varicella. No documentation was noted as to the number of the lesions that the child had. Subsequently, he recovered. It was reported that another patient (WAES0201USA02670) has a similar experience following exposure to Varivax. Additional information has been requested.
This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine was expired on 01-Apr-2022, stored in the refrigerator on 04-Apr-2022 and administered on 15-Apr-2022) and EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 01-Apr-2022 and administered on 15-Apr-2022) in an 86-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination. No Medical History information was reported. On 15-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 15-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 01-Apr-2022 and administered on 15-Apr-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was expired on 01-Apr-2022, stored in the refrigerator on 04-Apr-2022 and administered on 15-Apr-2022). At the time of the report, PRODUCT STORAGE ERROR (Vaccine was expired on 01-Apr-2022, stored in the refrigerator on 04-Apr-2022 and administered on 15-Apr-2022) and EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 01-Apr-2022 and administered on 15-Apr-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Date the vial was initially stored in the refrigerator on 04-Apr-2022. The vial did not undergo any temperature excursions. No treatment medications were reported.
Pt developed a rash beginning 2 days, post vax. Started on face and arms and progressed to trunk area and legs. Pt saw her PMD and he gave her an "antihistamine".
Information has been received from a health care professional concerning a 63 year old female who, on 6/3/99, was vaccinated with Hep-B vaccine recombinant. Concomitant medication included birth control pills. Subsequently, the pt experienced fatigue. Additionally, it was noted that the pt was vaccinated with an expired vaccine. Additional information has been requested.
Shot on Monday afternoon. Approximately Wednesday evening injection site started itching. Thursday morning there was a swollen area, redness and heat by injection. This is Saturday and I applied a warm cloth which made area feel better. has not affected lifestyle.
Simple Febrile Seizure at home, lasting no more than 5 minutes on 7/27/18, family concerns for decreased muscle strength and coordination following seizure. Fevers of 101-103. Second ED visit around 11:45pm 7/27/18 due to fever not responding to MOTRIN and TYLENOL- patient was under-dosed, fever control discussed in length. Complex febrile seizure in ED on 7/28/18, did not last past 5 minutes- neither had focality, neurology contacted and no further work up recommended. Rash started once fever broke and seizures stopped. Family history of febrile Seizures.
This case was reported by a pharmacist, who is also the subject and described the occurrence of possible Stevens Johnson syndrome in a 41-year-old male subject who was vaccinated with BOOSTRIX (GlaxoSmithKline). Concurrent medical conditions included seasonal allergy. Historic vaccination included Td vaccine (non-gsk); unknown given in 2001. Concurrent vaccination included HepA vaccine; manufacturer unspecified; unknown; unknown given on 15 November 2013. Concurrent medications included CLARITIN. On 15 November 2013 at 10:00 the subject received 1st dose of BOOSTRIX (.5 ml, unknown, right deltoid). On 15 November 2013, within hours of vaccination with BOOSTRIX, the subject experienced injection site redness, swelling injection site and generalized weakness. On 16 November 2013, one day after vaccination with BOOSTRIX, the subject experienced generalized myalgia, generalized arthralgia and sore throat. On 17 November 2013, two days after vaccination with BOOSTRIX, the subject experienced rash on trunk. On 18 November 2013, three days after vaccination with BOOSTRIX, the subject experienced "disperse rash to include extremities". The subject sought medical attention at the emergency department (ED). The pharmacist reported receiving BOOSTRIX on 15 November 2013, since then he has had weakness, redness and swelling at injection site, myalgia and sore throat. Also reported dispersed rash currently controlled by BENADRYL and prednisone as prescribed by emergency department (ED) physician he saw on 18 November 2013. It was reported that the managing physician is also considering a diagnosis of Steven Johnson. The pharmacist reported this was his first Tdap vaccine, previously he received a Td vaccine in 2001. This case was assessed as medically serious by GSK. At the time of reporting the outcome of the injection site redness, swelling injection site, generalized weakness, myalgia, arthralgia, sore throat, spreading rash, rash on trunk and possible Stevens Johnson syndrome were unspecified.
Bilateral lower abdominal distension; Lower back pain; I can barely get out of the bed/I cant put on my pants; Muscle pain; Headache; This spontaneous case was reported by a patient and describes the occurrence of ABDOMINAL DISTENSION (Bilateral lower abdominal distension), BACK PAIN (Lower back pain), BEDRIDDEN (I can barely get out of the bed/I cant put on my pants), MYALGIA (Muscle pain) and HEADACHE (Headache) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-May-2021, the patient experienced ABDOMINAL DISTENSION (Bilateral lower abdominal distension), BACK PAIN (Lower back pain), BEDRIDDEN (I can barely get out of the bed/I cant put on my pants), MYALGIA (Muscle pain) and HEADACHE (Headache). The patient was treated with IBUPROFEN at a dose of 1 dosage form. At the time of the report, ABDOMINAL DISTENSION (Bilateral lower abdominal distension), BACK PAIN (Lower back pain), BEDRIDDEN (I can barely get out of the bed/I cant put on my pants), MYALGIA (Muscle pain) and HEADACHE (Headache) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-May-2021, Body temperature: 101 (High) Low grade fever.   Action taken with mRNA-1273 in response to the events was not applicable     No concomitant medications provided  No treatment medications provided   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Follow up received on 25th may 2021 contains no new information
pt recvd vax 11 yrs ago; pt devel redness & soreness @ inj site & flu-like sx which lasted 3 wks;
Information has been received from a healthcare worker referring to an unspecified number of patients of unknown age and gender. On unknown dates the patients were vaccinated with improperly stored RECOMBIVAX HB (strength, lot#, expiration date, dose and route were unknown) (Incorrect product storage). The temperature excursion for RECOMBIVAX HB was supported with in-house stability data. No adverse symptoms were reported. This is one of several reports from the same reporter. Additional information has been requested.
Loss of appetite, Very Fatigue, weak, nausea, incoherent, disheveled,  muscle pain & weakness, pain on face/injection site. Reported to pain management dr. 9 days total. Treatment consisted of rest and continued pain management
Fever; This is a spontaneous report from a contactable consumer (patient). A 27-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL1283; Expiration Date: Apr2021), via an unspecified route of administration in left arm, on 19Jan2021 (Tuesday) at 13:45 (around 01:45 PM), at a single dose, for COVID-19 immunization. The patient's medical history included thyroid. The patient's concomitant medication included unspecified thyroid medication. The patient previously took the first dose of BNT162B2 (Lot Number: EH9899) on 29Dec2020 (in left arm) for COVID-19 immunization. The patient had no other recent vaccinations. The patient's work scheduled the vaccine for them through a third-party provider. The patient received her second dose of the vaccine on Tuesday and has a fever on Wednesday (20Jan2021) afternoon (about 12:00 PM) which continues to spike. For treatment, the patient took two of ibuprofen 200 mg, and didn't exceed 6 in a day; she took it every 8 hours or so by mouth. The patient didn't know if there were signs to be looking for. The patient's temperature from this this morning (21Jan2021) was 101 degrees Fahrenheit, which dropped to 99.6 degrees Fahrenheit, and is now 101.7 degrees Fahrenheit. The patient would like to know when she should be concerned and if there was a specific temperature to reach after which Pfizer advises to seek help. The patient had not recovered from the event.  No follow-up attempts are possible. No further information is expected.
Patient received FLUARIX vaccine on 10/22/2014 at 4pm. By evening he began to have a red spot. Mom felt it was normal. Within 24 hours he had LARGE swelling, redness, warmth/blistering 17mm x 15mm.
This spontaneous report as received from a healthcare worker refers to a 15 year old patient of unknown gender. The patient's medical history and current conditions were not provided. On 25-JUN-2015, the patient was vaccinated with a dose of improperly stored GARDASIL (strength, dose and route were not provided) lot # K023432 expiration date 18-JUN-2016. Concomitant medication was not reported. No adverse effects reported. This is one of several reports from the same source. Additional information has been requested.
Day 1 after the vaccine I felt the often reported fatigue and extreme soreness in the arm. However 12 days after the vaccine I noticed a red splotch at the vaccination site. It's about 4" in diameter, painless, flat without puritis. I looked it up and discovered it has been dubbed "COVID arm". I'm reporting this to help the CDC gather ACCURATE data regarding this vaccine and help stop misinformation about a potentially lifesaving vaccine. Thank you for all you do!
in 12 hr c/o arm pain & backache;during the noc had fever, chills, sweating;By 7AM this morning 8AUG95 cont w/chills & fever;muscle aches, h/a, weakness;taking Advil;advised to take temp & use APAP or ASA;inc fluids
tightness in chest, difficulty breathing;blood pressure elevated;p/40min into getting shot 144/98 which is high for pt;better p/40min-1hr feeling better;
red warm sore area left upper arm started morning after shot some increased redness since o/e 1 1/2 inch diameter red and mildly indurated area left upper arm, ice and observe
@ 1AM (9hr p/vax) awakened crying, mom feed, then noted shaking all over, grunt for breaths, turning blue;to ER temp 101.4;MD said febrile sz;mom reported no other s/s of other illness, sent home w/instructions for fever care;APAP given;
Body aches, nausea, vomiting, fatigue, sore arm difficulty moving arm from injection site, fever. Did not take medications. All have resolved except body aches.
I give patient a second Pfizer bivalent Covid booster today 2/14/2023 , and she had already received one ( Pfizer bivalent Covid  booster)on 9/29/22
Information has been received from a physician concerning a 16 year old female with no pertinent medical history who on 04-JUN-2007 was vaccinated intramuscularly with a 0.5 ml first dose of Gardasil (lot# 657868/0523U). Concomitant therapy included Ortho-Tri-Cyclen and Zyrtec. On 04-JUN-2007 the patient developed an injection site reaction. The physician reported that the injection site was "a 2 centimeter tall and a 2-3 centimeters wide area that was bruised, swollen, and tender to the touch and looked like the pointy end of an egg". There were no laboratory or diagnostic tests performed. No medical attention was sought. On approximately 11-JUN-2007 the patient recovered from the reaction. Additional information has been requested.
Patient reported arm soreness that occurred within 5 days of vaccine, worst symptoms involved inability to move arm, experienced 30 days after vaccine.
-pressure near eye and ear on L side of IZ -itching sensation in hairline, nose, ear, eye -rash, vesicles erupting on L side of face -Rx Valtrex 1 gm tid x 7d; Percocet prn. Referral to PCP and ophthalmic assessment.
Initial report received on 24 June 2009 from a health care professional. An 11 year old patient received a first time dose of DECAVAC (lot number U2348CA) intramuscularly in the right deltoid on 24 June 2009. Post vaccination, on 24 June 2009 the patient became dizzy, nauseous, and pale which lasted 20 minutes. However, the patient's recovery status was reported as unknown. The patient was given epinephrine and was sent home. No further information was reported. List of Documents held by Sender: none.
AFTER VACCINATION THE PATIENT DEVELOPED THE FOLLOWING SYMPTOMS:  VOMITING, HEADACHE, SWEATING, BECAME FLUSH, AND HAD A SENSITIVITY TO LIGHT. THE FACILITY MEDICAL DIRECTOR WAS CONTACTED IMMEDIATELY, 911 WAS CALLED, AND THE PATIENT WAS TAKEN TO THE LOCAL EMERGENCY ROOM WHERE SHE SEEN AND LATER RELEASED.  IT WAS NOTED THE PATIENT HAS A HISTORY OF REACTIONS WITH VACCINES IN THE PAST
Patient got rash from covid vaccin 15 days after the injection that traveled from her left side along her lymph nodes and collar bone. She wasn't sure if it was from the shot or not.